Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Costco says cooperating with DEA probe on controlled substances

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/17/2013 | 12:05am CET

Costco Wholesale Corp (>> Costco Wholesale Corporation) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA.

Costco Wholesale Corp (>> Costco Wholesale Corporation) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA.

The DEA has targeted large pharmacy chains and distributors to stem the flow of prescription drugs where abuse is suspected.

The DEA revoked the controlled substance licenses of two CVS Caremark Corp (>> CVS Caremark Corporation) drugstores in Florida in 2012, and earlier this year Walgreen Co (>> Walgreen Company) reached a record $80 million settlement with the agency to resolve allegations that its negligence in record-keeping and dispensing allowed highly addictive drugs to reach abusers and be sold illegally.

Costco announced its plans to cooperate with the DEA's subpoenas and administrative inspection warrants in a filing with the U.S. Securities and Exchange Commission on Wednesday. It said the matter concerned its "fulfillment of prescriptions related to controlled substances and related practices."

Additional details were not provided, and company representatives declined to comment beyond what was included in the regulatory filing.

(Reporting by Jessica Wohl in Chicago; Editing by Leslie Adler and Bob Burgdorfer)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
02/23 WALGREENS BOOTS ALLIANCE, INC. : Entry into a Material Definitive Agreement, Cre..
02/22 WALGREENS : Designates more than 50 Specialty Pharmacies as Cancer-Specialized L..
02/22 WALGREENS : Flu Index™ for Week of Feb. 19, 2017
02/16 WALGREENS BOOTS ALLIANCE : Flu Index for Week of Feb. 12, 2017; Brownsville, Tex..
02/16DJRetail CEOs Meet With Trump Over Border Tax Concerns -- Update
02/15DJRetail CEOs Meet With Trump Over Border Tax Concerns
02/15 WALGREENS : Flu Index™ for Week of Feb. 12, 2017
02/15 WALGREENS BOOTS ALLIANCE : and PeopleForBikes Launch 'Ride On' for Red Nose Day;..
02/14 Exclusive - Trump to meet with retail CEOs on taxes, infrastructure
02/13 WALGREENS BOOTS ALLIANCE INC : ex-dividend day
More news
Sector news : Drug Retailers - NEC
02/14DJEXPRESS SCRIPTS : Revenue Falls
02/09DJCVS HEALTH : Profit Rises, Helped by Pharmacy Strength -- Update
02/09DJCVS HEALTH : Profit Rises, Helped by Pharmacy Strength
02/07DJCARDINAL HEALTH : Again Trims 2017 Profit Forecast
02/01DJUnion Speaks Out Against Walgreens-Rite Aid Deal -- Update
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2017 118 792 M
EBIT 2017 7 496 M
Net income 2017 4 934 M
Debt 2017 8 289 M
Yield 2017 1,71%
P/E ratio 2017 19,16
P/E ratio 2018 17,26
EV / Sales 2017 0,87x
EV / Sales 2018 0,81x
Capitalization 94 567 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 94,3 $
Spread / Average Target 7,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%94 567
WALGREENS BOOTS ALLIAN..5.11%94 567
CVS HEALTH CORP2.47%83 574
EXPRESS SCRIPTS HOLDIN..3.11%43 339
MCKESSON CORPORATION6.07%31 988
CARDINAL HEALTH INC13.56%25 911
More Results